The survival, function, and hemolysis of human RBCs stored at 4°C in additive solution (AS-1, AS-3, or AS-5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4°C in sodium chloride and glucose solution for 24 hours

被引:30
作者
Valeri, CR [1 ]
Pivacek, LE [1 ]
Cassidy, GP [1 ]
Ragno, G [1 ]
机构
[1] Boston Univ, Sch Med, Naval Blood Res Lab, Boston, MA 02118 USA
关键词
D O I
10.1046/j.1537-2995.2000.40111341.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: A study was done to assess the quality of RBCs stored at 4 degreesC in AS-1, AS-3, or AS-5 for 42 days before biochemical modification and freezing. STUDY DESIGN AND METHODS: RBCs were stored at 4 degreesC for 42 days in AS-1, AS-3, or AS-5 and then biochemically modified with pyruvate, inosine, phosphate, and adenine solution (Rejuvesol), frozen with 40-percent (wt/vol) glycerol, and stored at -80 degreesC for at least 2 months. The RBCs were deglycerolized by the use of a cell washer (Haemonetics 115), and stored for 24 hours at 4 degreesC in a 0.9-percent sodium chloride and 0.2-percent glucose solution before the autologous transfusion. RESULTS: The mean freeze-thaw-wash recovery process produced RBC recovery values of 85 percent, with the mean 24-hour posttransfusion survival at 75 percent, and the mean index of therapeutic effectiveness at 64 percent for the RBCs stored at 4 degreesC in AS-1, AS-3, or AS-5 for 42 days before biochemical modification and freezing. All the units exhibited normal or slightly higher than normal 2,3 DPG levels after deglycerolization and postwash storage at 4 degreesC for 24 hours. CONCLUSION: RBCs stored in AS-1, AS-3, or AS-5 at 4 degreesC for 42 days and then biochemically modified with pyruvate, inosine, phosphate, and adenine and glycerolized, frozen, washed, and stored at 4 degreesC for 24 hours before autologous transfusion had acceptable in vitro and in vivo measurements.
引用
收藏
页码:1341 / 1345
页数:5
相关论文
共 18 条
[1]  
ASAKURA T, 1986, OXYGEN TRANSPORT RED, P57
[2]   SPECTROPHOTOMETRIC SCANNING TECHNIQUE FOR RAPID-DETERMINATION OF PLASMA HEMOGLOBIN [J].
BLAKNEY, GB ;
DINWOODIE, AJ .
CLINICAL BIOCHEMISTRY, 1975, 8 (02) :96-102
[3]  
LOCKWOOD W, 1997, TRANSFUSION S, V37, pS9
[4]   POSTTRANSFUSION SURVIVAL OF RED-CELLS FROZEN FOR 8 WEEKS AFTER 42-DAY LIQUID STORAGE IN AS-3 [J].
RATHBUN, EJ ;
NELSON, EJ ;
DAVEY, RJ .
TRANSFUSION, 1989, 29 (03) :213-217
[5]   COMPARISON OF EFFECTS OF IONIC AND NON-IONIC SOLUTIONS ON VOLUME AND INTRACELLULAR POTASSIUM OF FROZEN AND NON-FROZEN HUMAN RED CELLS [J].
RUNCK, AH ;
VALERI, CR ;
SAMPSON, WT .
TRANSFUSION, 1968, 8 (01) :9-&
[6]  
Trautschold I., 1963, METHODS ENZYMATIC AN, P543
[7]   VIABILITY AND FUNCTION OF OUTDATED HUMAN RED-BLOOD-CELLS AFTER BIOCHEMICAL MODIFICATION TO IMPROVE OXYGEN-TRANSPORT FUNCTION, FREEZING, THAWING, WASHING, POST-THAW STORAGE AT 4-C, PERFUSION INVITRO THROUGH A BUBBLE OXYGENATOR, AND AUTO-TRANSFUSION [J].
VALERI, CR ;
VECCHIONE, JJ ;
PIVACEK, LE ;
LOWRIE, GB ;
AUSTIN, RM ;
EMERSON, CP .
TRANSFUSION, 1980, 20 (01) :39-46
[8]   BIOCHEMICAL MODIFICATION AND FREEZE-PRESERVATION OF RED BLOOD-CELLS - NEW METHOD [J].
VALERI, CR ;
VALERI, DA ;
DENNIS, RC ;
VECCHIONE, JJ ;
EMERSON, CP .
CRITICAL CARE MEDICINE, 1979, 7 (09) :439-447
[9]   IMPROVED OXYGEN DELIVERY TO THE MYOCARDIUM DURING HYPOTHERMIA BY PERFUSION WITH 2,3 DPG-ENRICHED RED BLOOD-CELLS [J].
VALERI, CR ;
YARNOZ, M ;
VECCHIONE, JJ ;
DENNIS, RC ;
ANASTASI, J ;
VALERI, DA ;
PIVACEK, LE ;
HECHTMAN, HB ;
EMERSON, CP ;
BERGER, RL .
ANNALS OF THORACIC SURGERY, 1980, 30 (06) :527-535
[10]   THERAPEUTIC EFFECTIVENESS AND SAFETY OF OUTDATED HUMAN RED-BLOOD-CELLS REJUVENATED TO IMPROVE OXYGEN-TRANSPORT FUNCTION, FROZEN FOR ABOUT 1.5 YEARS AT 80-C, WASHED, AND STORED AT 4-C FOR 24 HOURS PRIOR TO RAPID INFUSION [J].
VALERI, CR ;
ZAROULIS, CG ;
VECCHIONE, JJ ;
VALERI, DA ;
ANASTASI, J ;
PIVACEK, LE ;
EMERSON, CP .
TRANSFUSION, 1980, 20 (03) :263-276